Medicinal Chemistry

(Jacob Rumans) #1

The 1,4-dihydropyridines are the best studied Ca2+channel antagonists. A number of
analogs within this series have been developed: amlodipine (7.40), felodipine (7.41),
isradipine (7.42), nicardipine (7.43), nifedipine (7.38), nimodipine (7.37), nitrendipine
(7.44), and nisoldipine (7.45). From a pharmacokinetic perspective, these agents vary
widely: nisoldipine has only 5% oral bioavailability, whereas amlodipine has 80–90%
oral bioavailability; nimodipine has an elimination half-life of 1–2 hours whereas
amlodipine’s half-life is 40–50 hours. The 1,4-DHPs, in general, undergo extensive
first-pass metabolism; in many cases, the dihydropyridine ring is initially oxidized to a
pyridine analog. Pharmacodynamically, the 1,4-DHPs bind to the α-1 subunit of the
L-type Ca^2 +channel protein. This protein readily changes shape in response to the trans-
membrane voltage gradient and exists in three primary conformations: “resting” (can be
stimulated to open by a membrane depolarization), “open” (permitting Ca^2 +to enter),
and “inactive” (temporarily refractory to depolarization-induced opening). 1,4-DHPs
preferentially bind to the L-type channel protein when it is in either the “open” or the
“inactive” conformation; such conformation-dependent binding is referred to as “use-
dependent binding.” Due to allosteric interactions between receptors, verapamil inhibits
the binding of 1,4-DHPs to the Ca^2 +channel, whereas diltiazem enhances 1,4-DHP
binding.


These various pharmacokinetic and pharmacodynamic properties have enabled the
identification of four basic structure–activity rules for the 1,4-DHP antagonists:



  1. The 1,4-DHP ring is essential for bioactivity; the use of reduced (pyridine) or oxi-
    dized (piperidine) ring systems reduces activity; substitution at the N1 position
    reduces activity

  2. Ester groups at the C3 and C5 positions optimize activity; when the C3 and C5 esters
    are nonidentical, the C4 carbon becomes chiral; such asymmetrical compounds
    exhibit enhanced selectivity for specific blood vessels


428 MEDICINAL CHEMISTRY

Free download pdf